Intact Vascular, Inc., a Wayne, PA-based developer of medical devices for minimally invasive peripheral vascular procedures, has closed a $15.5m Series A financing.
The company intends to use the proceeds to continue clinical studies of the Tack-It Endovascular Stapler System™, a novel endovascular stapling device designed to optimize peripheral angioplasty results for the treatment of peripheral artery disease (PAD).
In conjunction with the close of the financing, Dennis Wahr, M.D., former CEO of Lutonix, has been appointed Chairman of the Board of Directors. He has joined
Carol A. Burns, President and CEO of Intact Vascular,
Kathy Crothall, President and CEO of Aspire Bariatrics,
Aaron Davidson, Managing Director at H.I.G. BioVentures,
Wes Kaupinen, Principal at Quaker Partners, and
Peter A. Schneider, M.D., Co-Founder and Chief Medical Officer of Intact Vascular.